78 results
8-K
EX-99.1
GILD
Gilead Sciences, Inc.
22 Mar 24
Gilead Sciences Announces Completion of Acquisition of Cymabay
9:21am
ANNOUNCES COMPLETION OF ACQUISITION OF CYMABAY
Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver
SC TO-T
EX-99
CBAY
Cymabay Therapeutics Inc
23 Feb 24
Third party tender offer statement
6:09am
USA), where she was a member of the faculty for more than 30 years and served as the Norman Davidson Leadership Chair of the division from 2009 … more than 20 years of increasing company leadership and commitment to transforming care delivery for patients with
Schedule A-4
Name, Country
8-K
EX-99.1
qy03tp 3opp484yuzg
3 Aug 23
Gilead Sciences Announces Second Quarter 2023 Financial Results
4:07pm
PX14A6G
ls292xde
11 Apr 22
Letter to shareholders
6:01am
8-K
EX-99.1
k84d q2unbeyci5qcx
29 Apr 21
Gilead Sciences Announces First Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
kijl7yhfugz4xspi0i
4 Feb 21
Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results
4:05pm
SC TO-T
EX-99
ptbx1s wq6rtu9q4
24 Sep 20
Third party tender offer statement
8:00am
SC TO-C
EX-99.1
u6jfb
17 Sep 20
Information about tender offer
4:53pm
SC TO-C
EX-99.2
2bn8xve5o hq
14 Sep 20
Information about tender offer
5:28pm
SC TO-C
EX-99.3
rtevek 9670tdisx6k
14 Sep 20
Information about tender offer
5:28pm
8-K
EX-99.1
t5kpp
30 Jul 20
Gilead Sciences Announces Second Quarter and First Half 2020 Financial Results
6:57pm